New Zealand markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
39.55+0.09 (+0.23%)
At close: 4:00PM EDT
39.70 +0.15 (+0.38%)
Pre-market: 09:05AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 596.24B
Enterprise value 3126.20B
Trailing P/E 16.46
Forward P/E 112.41
PEG ratio (5-yr expected) 13.41
Price/sales (ttm)2.19
Price/book (mrq)4.67
Enterprise value/revenue 33.84
Enterprise value/EBITDA 711.89

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 312.07%
S&P500 52-week change 331.29%
52-week high 342.68
52-week low 333.26
50-day moving average 339.11
200-day moving average 339.28

Share statistics

Avg vol (3-month) 33.71M
Avg vol (10-day) 34.4M
Shares outstanding 52.52B
Implied shares outstanding 6N/A
Float 82.45B
% held by insiders 10.01%
% held by institutions 113.04%
Shares short (29 Sep 2021) 417.57M
Short ratio (29 Sep 2021) 45.01
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.70%
Shares short (prior month 30 Aug 2021) 416.44M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 45.57%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 32.03%
5-year average dividend yield 45.24
Payout ratio 491.41%
Dividend date 306 Oct 2021
Ex-dividend date 418 Aug 2021
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 13.34%
Operating margin (ttm)24.85%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)24.29%

Income statement

Revenue (ttm)32.9B
Revenue per share (ttm)13.18
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)23.21B
Net income avi to common (ttm)4.39B
Diluted EPS (ttm)2.39
Quarterly earnings growth (yoy)-38.40%

Balance sheet

Total cash (mrq)3.56B
Total cash per share (mrq)1.42
Total debt (mrq)25.48B
Total debt/equity (mrq)118.10
Current ratio (mrq)0.82
Book value per share (mrq)6.14

Cash flow statement

Operating cash flow (ttm)6.34B
Levered free cash flow (ttm)6.95B